Express delivery and free returns within 21 days

Friday, July 1, 2022



Contact us 561.316.3330

The Leukemia and Lymphoma Society Announces Winners of 2020 Man & Woman of the Year Fundraising Competition

The Leukemia and Lymphoma Society (LLS), a global leader in the fight against cancer, is not immune to the damaging impact of the COVID-19 pandemic. But thousands of participants in nearly 100 communities across the country remain laser-focused on their pursuit of a world without blood cancer, taking on LLS’s 10-week philanthropic competition, Man & Woman of the Year®, by storm — even if it means pivoting to the world of virtual fundraising.

LLS announced today, Rich Pentz and Tina Swallow were awarded the prestigious titles, National Man of the Year and National Woman of the Year, and broke new local campaign records, raising $518,906 and $467,686 respectively. The campaign has helped LLS invest nearly $1.3 billion, ensuring that the organization continues to deliver its cancer curing mission and impact for patients, who need support now, more than ever.

The funds raised through Man & Woman of the Year are used for:

  • Research to advance lifesaving therapies like immunotherapy, genomics and personalized medicine, which are saving lives today.
  • Free blood cancer information, education and support for patients and families.
  • National and local advocacy efforts driving policies that accelerate new treatments and ensure patients have access to care so that they can live longer, healthier lives.

“Cancer will not wait for COVID-19 to go away. And cancer patients can’t wait either,” said Louis J. DeGennaro, Ph.D., LLS president and CEO. “With the grit and determination of LLS supporters and volunteers like our Man & Woman of the Year candidates, LLS maintains a very significant, impactful mission agenda. We will continue to forge ahead relentlessly to find cures and help blood cancer patients access the care they need.”

Pentz, a senior director of institutional sales and relationship management at Principal Global Investors in Indianapolis, IN, spearheaded “Team Echo” after accepting his nomination in memory of his mother, Patricia, who lost her battle to acute myeloid leukemia six years ago. He leveraged social media and organized innovative fundraising tactics in lieu of his other event plans, which were canceled due to COVID-19. Pentz said he was “elated beyond words” to find out his campaign, which culminated on his mother’s birthday, June 20, broke a new fundraising record for Indiana. “It’s not about winning the title, it’s about the impact we’re making on the cancer landscape,” said Pentz.

Swallow, a 21-year Navy veteran and services director at Cisco in Washington, D.C., led “Team Bridge to a Cure” and ran her campaign in honor of her oldest son, Beau, who survived stage 4 cancer. “I’ve made it my mission to never stop fighting for cancer cures,” said Swallow. “Just like LLS, my mission has not changed, what has changed is the urgency for patients.”

The National Man & Woman of the Year runners-up were Jesse Giordano of “Team Unity” of Opal Wealth Advisors in Long Island, NY, and Lauren Palmer of “Team Gold” in Charlotte, NC — they raised $437,510 and $352,792, respectively. The National “All Star” winners were Brian Fuller of “Team Lexie’s Legacy” in Atlanta, GA, and Allison Jockel of “Team AML All Stars” in Charlotte, NC. Collectively, they raised more than $542,192. Fuller broke a new national All Star fundraising record and ran his campaign in memory of Lexie Clayton, a former LLS staff member who passed away from cancer at 36 years old.

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.
Subscribe to Medical Device News Magazine

NeuroVasc Technologies Announces First Patient Treated in Clinical Trial to Evaluate Its Novel Stent-Retriever

This trial will evaluate the safety and efficacy of the NeuroVasc ENVI™-SR, a stent-retriever intended for the treatment of acute ischemic stroke to reduce disability by removing blood clots in patients with stroke due to large vessel occlusion.

Neuromod Publishes Results of Second Large Scale Clinical Trial for Tinnitus in Top-Tier Scientific Journal

Speaking on the news, Dr Ross O’Neill, Founding CEO of Neuromod said, “We’re delighted to announce the publication of positive results from the TENT-A2 clinical trial which show greater improvement in tinnitus symptoms from treatment with Lenire. Tinnitus remains one of the largest unmet clinical needs globally and I’m proud that Neuromod is at the forefront of developing bimodal neuromodulation technology to treat chronic tinnitus.

A Randomized MRI-Based Study Reveals VasQ External Support Promotes More Stable Hemodynamics than Standard AVFs

VasQ External Support, a Laminate Medical Technologies device is implanted around the connection between the vein and artery during the creation of an arteriovenous fistula (AVF) for hemodialysis patients with the intent to provide structural reinforcement and promote a more stable flow profile.

By using this website you agree to accept Medical Device News Magazine Privacy Policy